SCHEMBL9921332

SCHEMBL9921332

Cc1nc(NCCc2ccc(C(F)(F)F)cc2)c2cc(F)cnc2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE2A O00408 2/20 0.47
▸ EGFR P00533 1/20 0.38
▸ PDGFRB P09619 1/20 0.38
▸ KDR P35968 1/20 0.38
▸ HTT P42858 2/20 0.38
▸ ACP1 P24666 1/20 0.38
▸ MDM2 Q00987 1/20 0.38
▸ CRHR1 P34998 1/20 0.37
▸ CCNC P24863 1/20 0.37
▸ CDK8 P49336 1/20 0.37
▸ AURKA O14965 2/20 0.36
▸ AURKB Q96GD4 2/20 0.36
▸ F2 P00734 1/20 0.36
▸ PRSS1 P07477 1/20 0.36
▸ PRSS2 P07478 1/20 0.36
▸ PRSS3 P35030 1/20 0.36
▸ MKNK2 Q9HBH9 1/20 0.36
▸ NTRK1 P04629 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13171141 0.89 MAPT (0.42) HTTKDM4EALDH1A1LMNAMAPT
SCHEMBL9921324 0.87 PDE2A (0.44) PDE2AEGFRHTTACP1MDM2
SCHEMBL9921338 0.87 PDE2A (0.45) PDE2AEGFRKDRHTTACP1
SCHEMBL9921422 0.83 HTT (0.50) PDE2AEGFRHTTCCNCCDK8
SCHEMBL9921328 0.82 KRAS (0.50) PDE2AHTTACP1CCNCCDK8
SCHEMBL13171179 0.77 HTT (0.41) HTTKDM4ELMNAMAPT
SCHEMBL13171102 0.76 GALR3 (0.41) HTTKDM4ELMNAMAPT
SCHEMBL9921444 0.75 EGFR (0.45) PDE2AEGFRHTTMDM2AURKA
SCHEMBL9921323 0.73 HTT (0.52) EGFRHTTLMNAMAPTSMN1; SMN2
SCHEMBL9921339 0.72 HTT (0.51) PDE2AHTTACP1CCNCCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY (CN) 2012-10-11 — — US disclosed
WO-2012079079-A1 PRODUCTION OF INDUCED PLURIPOTENT STEM CELLS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-06-14 — — WO disclosed
WO-2011011522-A2 POTENT SMALL MOLECULE INHIBITORS OF AUTOPHAGY, AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2011-01-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof ATG7, BECN1, SQSTM1 PDE2A 3240/4885EGFR 2099/4885PDGFRB 1981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback